Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The platinum–DNA crosslink induced by carboplatin is a DNA lesion formed when the platinum atom in carboplatin covalently binds to DNA, typically at the N7 site on guanine bases. Carboplatin primarily creates intrastrand crosslinks but can also induce interstrand crosslinks, which are especially cytotoxic as they block separation of the DNA strands, preventing replication and transcription. These DNA crosslinks trigger the cellular DNA damage response, leading to cell cycle arrest and apoptosis—primary mechanisms of chemotherapy-induced tumor cell death. This process is a major mechanism for the anticancer effects of carboplatin and related platinum drugs, but it is not a discrete molecular entity or classic 'target' like a receptor or enzyme.
Formation of DNA interstrand and intrastrand crosslinks through covalent binding of platinum to DNA (primarily at the N7 position of guanine). Crosslinking blocks DNA replication and transcription, leading to cell cycle arrest and apoptosis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platinum–DNA crosslink (carboplatin-induced).